Source: Annual Congress 2005 - Sleep apnoea in children
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
A. G. Kaditis, E. I. Alexopoulos, E. Kalampouka, I. Karadonta, T. Kyropoulos, E. Kostadima, K. Gourgoulianis, G. Syrogiannopoulos (Larissa, Greece). Plasma levels of vascular endothelial growth factor in children with sleep-disordered breathing. Eur Respir J 2005; 26: Suppl. 49, 1615

Member's Comments

No comment yet.

Related content which might interest you: Plasma vascular endothelial growth factor levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004 Correlation between morning ghrelin levels and polysomnography indices in children with sleep-disordered breathing Source: Annual Congress 2005 - Sleep apnoea in children Year: 2005 Determinant factors of serum leptin levels in patients with obstructive sleep apnea Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA) Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 CPAP decreases plasma levels of soluble tumour necrosis factor-α receptor 1 in obstructive sleep apnoea Source: Eur Respir J 2008; 32: 1009-1015 Year: 2008 Association between C-reactive protein and unrecognised sleep-disordered breathing in the elderly Source: Eur Respir J 2009; 33: 797-803 Year: 2009 Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment Source: Eur Respir J 2003; 22: 251-257 Year: 2003 Serum vitamin D levels are associated with markers of hypoxia in obstructive sleep apnea patients Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013 Day–night variations in endothelial dysfunction markers and haemostatic factors in sleep apnoea Source: Eur Respir J 2012; 39: 913-918 Year: 2012 Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea Source: Eur Respir J 2009; 33: 793-796 Year: 2009 Plasma adiponectin levels and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2004 - Systemic and metabolic effects from OSA Year: 2004 Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 Morning levels of fibrinogen in children with sleep-disordered breathing Source: Eur Respir J 2004; 24 : 790-797 Year: 2004 Severe sleep apnea during REM sleep is associated with decreased levels of anti-inflammatory proteins - A proteomic approach to study the impact of sleep-disordered breathing Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view Year: 2019 Effects of continuous nocturnal high oxygen concentrations in obstructive sleep apnea patients Source: Annual Congress 2005 - Control of breathing Year: 2005 Is obstructive sleep apnoea a risk factor for cardiovascular disease? Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy Year: 2005 Plasma levels of TNF in obstructive sleep apnea syndrome (OSA) before and after surgical intervention Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012 Increased troponin T levels in haemodialysis patients are not associated with sleep related breathing disorders Source: Annual Congress 2005 - What should we know about our SAS patients Year: 2005 Serum and mucosal brain derived neurotrophic factor (BDNF) in severe obstructive sleep apnea syndrome (OSAS). Effects of CPAP treatment on BDNF serum levels. Source: International Congress 2019 – Beyond continuous positive airway pressure treatment Year: 2019 Serum resistin level in pediatric obstructive sleep apnea Source: Annual Congress 2008 - Paediatric respiratory epidemiology I: primary ciliary dyskinesia, sleep-disordered breathing, exercise-induced symptoms and rare diseases Year: 2008